Cargando…
A Hidden Epidemic of “Intermediate Risk” Oropharynx Cancer
OBJECTIVES: Oropharyngeal squamous cell carcinoma (OPSCC) incidence is rapidly increasing in the United States and around the world, driven in large part by infection with the human papillomavirus (HPV). HPV associated OPSCC (HPV+OPSCC) has been shown to have improved response to treatment relative...
Autores principales: | Sandulache, Vlad C., Wilde, David C., Sturgis, Erich M., Chiao, Elizabeth Y., Sikora, Andrew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929570/ https://www.ncbi.nlm.nih.gov/pubmed/31890879 http://dx.doi.org/10.1002/lio2.316 |
Ejemplares similares
-
Treatment Patterns in Veterans with Laryngeal and Oropharyngeal Cancer and Impact on Survival
por: Richardson, Peter A., et al.
Publicado: (2018) -
Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes
por: Soliman, Ola, et al.
Publicado: (2023) -
Quantifying smoking exposure, genomic correlates, and related risk of treatment failure in p16+ squamous cell carcinoma of the oropharynx
por: Schrank, Travis, et al.
Publicado: (2021) -
Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients
por: Karakullukcu, Baris, et al.
Publicado: (2010) -
Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study
por: Borggreven, Pepijn A., et al.
Publicado: (2007)